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Objective: Debate continues as to whether transhiatal esophagectomy results in
lower morbidity and mortality than transthoracic esophagectomy. Most data ad-
dressing this issue are derived from single-institution studies. To investigate this
question from a nationwide multicenter perspective, we used the Veterans Admin-
istration National Surgical Quality Improvement Program to prospectively analyze
risk factors for morbidity and mortality in patients undergoing transthoracic esoph-
agectomy or transhiatal esophagectomy from 1991 to 2000.
Methods: Univariate and multivariate analyses were performed on 945 patients (mean
age, 63 10 years). There were 562 transthoracic esophagectomies and 383 transhiatal
esophagectomies in 105 hospitals, with complete 30-day outcomes recorded.
Results: There were no differences in recorded preoperative variables between the
groups that might bias any comparisons. Overall mortality was 10.0% (56/562) for
transthoracic esophagectomy and 9.9% (38/383) for transhiatal esophagectomy
(P  .983). Morbidity occurred in 47% (266/562) of patients after transthoracic
esophagectomy and in 49% (188/383) of patients after transhiatal esophagectomy
(P  .596). Risk factors for mortality common to both groups included a serum
albumin value of less than 3.5 g/dL, age greater than 65 years, and blood transfusion
of greater than 4 units (P  .05). When comparing transthoracic esophagectomy
with transhiatal esophagectomy, there was no difference in the incidence of respi-
ratory failure, renal failure, bleeding, infection, sepsis, anastomotic complications,
or mediastinitis. Wound dehiscence occurred in 5% (18/383) of patients undergoing
transhiatal esophagectomy and only 2% (12/562) of patients undergoing transtho-
racic esophagectomy (P  .036).
Conclusions: These data demonstrate no significant differences in preoperative
variables and postoperative mortality or morbidity between transthoracic esopha-
gectomy and transhiatal esophagectomy on the basis of a 10-year, prospective,
multi-institutional, nationwide study.
There is ongoing debate as to whether transhiatal esophagectomy(THE) results in lower morbidity and mortality than transthoracicesophagectomy (TTE). Most data addressing this issue come fromsingle-institution studies. To investigate this question from a nation-wide multicenter perspective, we used the Department of VeteranAffairs (VA) National Surgical Quality Improvement Program. This
article prospectively analyzes risk factors for morbidity and mortality and compares
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outcomes in patients undergoing TTE or THE from January
1991 to December 2000.
Patients and Methods
There were 109 VA centers contributing prospectively collected
data from patients undergoing esophagectomy between January
1991 and December 2000. A total of 945 patients had an esoph-
ageal resection: 383 THEs (Current Procedural Terminology codes
43107-43108) and 562 TTEs (Current Procedural Terminology
codes 43112, 43113, 43117, 43118, and 43121). Published reports
describe the methods of the VA National Surgical Quality Im-
provement Program.1-4
A trained nurse reviewed each patient’s chart and recorded 122
individual variables for each operation. Reviewers were continu-
ally tested and monitored on a set of standard criteria and defini-
tions for each variable. The recorded variables were selected by a
panel of surgical experts, as well as from literature reviews.
Laboratory values and demographics were automatically down-
loaded to the statistical center from computers at each participating
VA medical center. Audits were frequently performed to ensure
accurate and reliable data collection. Periodic internal and random
external audits for data quality were performed at every center.
A multivariable logistic regression analysis was used to deter-
mine which preoperative and intraoperative patient-specific factors
were good predictors of mortality and morbidity. Important pre-
dictive factors were first analyzed by means of bivariate analyses.
Namely, the association of demographic and laboratory variables
with 30-day morbidity and mortality was investigated. The un-
paired t test was used for continuous variables, and the 2 test was
used for categoric variables. A prevalence of greater than 0.5% and
significance by means of bivariate analysis defined as a P value of
less than .20 were used for selection of potential independent
variables for the multivariable logistic regression analysis. Entry
and exit criteria set at a level of 0.10 and 0.05, respectively, were
used for the stepwise logistic regression, with mortality or mor-
bidity as the dependent variable. In the morbidity analyses the
dependent variable was the presence or absence of at least one
serious complication.
The risk-stratification model was created for the entire data set
(945 patients) by using the methods explained by Le Gall and
colleagues.5 Briefly, our scoring system for each patient’s mortal-
ity and morbidity was based on the multivariate logistic regression
models that contained only preoperative factors. Each  coefficient
taken from the logistic model was multiplied by 10 and rounded
off to the nearest integer (except age coefficient). In this way we
weighted the significance of risk factors. For each patient, we
assigned a mortality and morbidity score equal to the sum of all
risk factor points.
Results
From January 1991 through December 2000, 945 patients
underwent esophagectomy. Among these patients, 562
(59.5%) underwent TTE, whereas 383 (40.5%) underwent
THE. The mean age was 63.4 years for the TTE group and
63.2 years for the THE group (P  .83). Cancer was the
indication for surgical intervention in 85.2% (479/562) of
patients undergoing TTE and 86.4% (331/383) of patients
undergoing THE (P 1.0). Thirty-day mortality was 10.0%
(56/562) for the TTE group and 9.9% (38/383) for the THE
group (P  .983). Any morbidity occurred in 47.3% (266/
562) of patients undergoing TTE and 49.1% (188/383) of
patients undergoing THE (P .596). Serious morbidity was
seen in 41.6% (234/562) of patients undergoing TTE and
41.8% (160/383) of patients undergoing THE (P  .969).
Serious morbidity was defined as pneumonia, unplanned
reintubation, failure to wean from the ventilator within 48
hours, pulmonary embolus, pulmonary edema, cardiac ar-
rest requiring cardiopulmonary resuscitation, myocardial
infarction, wound dehiscence, coma for longer than 24
hours, acute renal failure, systemic sepsis, perioperative
bleeding of greater than 4 units, and graft or prosthesis
failure (Table 1).
Pulmonary complications, including pneumonia, failure
to wean within 48 hours, and reintubation for respiratory
distress, were the most common morbidities in both groups.
Pneumonia was seen statistically more often in patients
undergoing TTE (26% for TTE vs 18% for THE, P .007).
However, there was no difference in the number of patients
extubated after 48 hours or in unplanned intubations. Sys-
temic sepsis was the next most common morbidity after
both procedures. Other morbidities and their frequencies are
shown in Table 1. Wound disruptions were seen in 5%
(18/383) of patients undergoing THE and 2% (12/562) of
patients undergoing TTE (P  .036). Postoperative myo-
cardial infarction occurred in 1% (7/562) of patients under-
going TTE and no patients undergoing THE (P  .046).
The incidence of pre-existing pulmonary disease or risk
factors, including smoking, dyspnea, severe chronic ob-
structive pulmonary disease (COPD; defined as dyspnea
with minimal exertion or dyspnea at rest), and current
pneumonia, did not differ between the 2 groups. Heavy
alcohol use, dependent functional status, or immunosup-
pressed states, such as diabetes mellitus, disseminated can-
cer, steroid use, and chemotherapy within 30 days before
surgical intervention, did not differ between the TTE and
THE groups (Table 2). Likewise, serum creatinine levels,
blood urea nitrogen levels, alkaline phosphatase values,
platelet counts, and prothrombin times did not vary between
the TTE and THE groups (Table 3). However, patients
undergoing TTE had lower mean albumin values (P  .01),
had lower mean hematocrit values (P  .001), underwent
more emergency operations (P  .008), and had more
American Society of Anesthesiologists classes of 3 or
greater (P  .009).
Albumin values of 3.5 g/dL or less, dyspnea, and a
preoperative red blood cell transfusion of greater than 4
units were risk factors for morbidity in the TTE group on
the basis of the multivariable analysis. The following risk
factors were predictive of mortality after TTE: current pneu-
monia, preoperative weight loss of greater than 10%, ad-
vanced age, and preoperative red blood cell transfusion of
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greater than 4 units. The risk factors for morbidity after
THE were as follows: diminished functional health, current
smoking, dyspnea, prolonged operative time, advanced age,
and a preoperative albumin value of 3.5 g/dL or less. Risk
factors for mortality after THE were as follows: creatinine
level of greater than 1.2 mg/dL, albumin value of 3.5 g/dL
or less, and a diminished functional health.
We also evaluated whether the number of esophagecto-
TABLE 2. Frequency of dichotomous variable comorbidities in 562 patients undergoing TTE and 383 patients undergoing
THE
Variable TTE, n (%) THE, n (%) P value
Diabetes mellitus, oral control 38 (7) 35 (9)
Insulin control 29 (5) 20 (5) .434
Smoke 1 y 258 (47) 159 (52) .139
Alcohol use 3 drinks/d 110 (20) 65 (17) .267
Dyspnea
Exertion 104 (19) 66 (17)
At rest 15 (3) 4 (1) .166
Functional health-dependent 41 (7) 26 (7) .953
Severe COPD 134 (24) 88 (23) .815
Current pneumonia 8 (1) 4 (1) .770
Disseminated cancer 47 (8) 23 (6) .206
Steroid use 11 (2) 12 (3) .285
10% weight loss 186 (33) 126 (30) .394
Bleeding disorder 14 (3) 4 (1) .146
Emergency 19 (3) 3 (1) .008
ASA III or IV 106 (19) 39 (10) .009
Chemotherapy within 30 d 63 (12) 42 (12) .916
DNR 4 (1) 5 (1) .497
ASA, American Society of Anesthesiologists; DNR, do not resuscitate.
TABLE 1. Observed 30-day mortality and morbidity by operative procedure
Variable TTE, n  562 (%) THE, n  383 (%) P value
30-d mortality 56 (9.96%) 38 (9.92%) .93
30-d morbidity (1 serious complication) 234 (41.64) 160 (41.78) .99
Respiratory complications
Pneumonia* 145 (26%) 70 (18%) .007
Unplanned reintubation* 98 (17%) 61 (16%) .595
Failure to wean 48 h* 101 (18%) 84 (22%) .134
Pulmonary embolus* 6 (1%) 2 (1%) .485
Cardiac complications
Pulmonary edema* 1 (0%) 4 (1%) 1.000
Cardiac arrest with CPR* 25 (4%) 21 (5%) .538
Myocardial infarction* 7 (1%) 0 (0%) .046
Wound complications
Superficial wound infection 26 (5%) 23 (6%) .372
Deep wound infection 23 (4%) 20 (5%) .430
Wound dehiscence* 12 (2%) 18 (5%) .036
CNS complications
Coma 24 h* 1 (0%) 2 (1%) 1.000
Cerebral vascular accident* 3 (1%) 0 (0%) 1.000
Urinary tract complications
Urinary tract infection 25 (4%) 19 (5%) .754
Progressive renal insufficiency 19 (3%) 8 (2%) .320
Acute renal failure* 6 (1%) 7 (2%) .320
Other complications
Systemic sepsis* 52 (9%) 30 (8%) .482
Bleeding requiring 4 units transfused* 11 (2%) 13 (3%) .207
Graft-prosthesis failure* 4 (1%) 0 (0%) 1.000
CPR, Cardiopulmonary resuscitation; CNS, central nervous system.
*Serious complication.
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mies performed per center affected morbidity and mortality
rates for both groups. We defined lower-volume centers as
performing 10 or fewer esophagectomies over the time
course of the study and higher-volume centers as perform-
ing greater than 10 esophagectomies over the time course of
the study. TTE mortality in lower-volume centers was
10.0% (36/369), and TTE mortality in higher-volume cen-
ters was 10.4% (20/193, P  .92). Serious morbidity after
TTE was seen in 42.5% (157/369) of patients in lower-
volume centers and 31.7% (61/193) of patients in higher-
volume centers (P  .45). Mortality rates after THE were
8.9% (11/128) in higher-volume centers and 9.5% (24/255)
in lower-volume centers (P  .86). Serious morbidity after
THE was seen in 52.9% (135/255) in higher-volume centers
and 45.0% (58/128) in lower-volume centers (P  .27).
A risk-stratification model was applied to the entire co-
hort (Tables 4 and 5). Parameters for mortality included
albumin values of 3.5 g/dL or less, age, dyspnea, and
functional status. Patients with scores of 0 to 4 points had a
mortality of 2.5%, patients with scores of 1 to 5 points had
10.7% mortality, and patients with scores of greater than 12
points had 17% mortality. Significant risk factors for mor-
bidity included albumin values of 3.5 g/dL or less, creati-
nine levels of greater than 1.2 mg/dL, alkaline phosphatase
values of greater than 125 U/L, prothrombin times of greater
than 12 seconds, diminished functional status, and a history
of severe COPD (Table 5). Patients without risk factors had
a morbidity of 29.6%. Patients with scores of 1 to 6 points
had a 32.7% incidence of morbidity, patients with scores of
7 to 12 points had 51.0% morbidity, and patients with scores
of greater than 12 points had 59.4% morbidity.
Discussion
In this prospective multi-institutional study over 10 years,
we found no significant difference in morbidity and mor-
tality when comparing TTE with THE. The mortality rate
for both procedures considered in our study was 10%, and
overall morbidity approached 50%, whereas serious mor-
bidity was seen in 41% of patients. The most common
complications were pulmonary. Overall, the TTE group
appeared to have a slightly higher preoperative severity.
Specifically, this group was more likely to have a preoper-
ative albumin value of less than 3.5 g/dL, have abnormal
serum sodium levels, undergo an emergency operation, and
have an ASA class of 3 or greater. Multivariable risk factors
that appeared more than once for morbidity or mortality in
the TTE or THE groups included the following: age, intra-
operative red blood cell units of transfusion, albumin values
of less than 3.5 g/dL, diminished functional status, and
dyspnea. A number of other factors were identified for risks
of either morbidity or mortality for THE or TTE alone.
On the basis of our risk-stratification model, we have
identified the most important risk factors for morbidity and
mortality. These include the following: COPD, dyspnea,
diminished functional health, advanced age, albumin value
of 3.5 g/dL or less, alkaline phosphatase value of greater
than 125 U/L, creatinine level of greater than 1.2 mg/dL,
and prothrombin time of greater than 12 seconds. On the
basis of our risk-stratification system, surgeons can predict
outcomes on the basis of preoperative risk factors.
This study constitutes the largest prospective cohort
comparing outcomes after TTE and THE. Two prospective
randomized studies with much smaller numbers corroborate
our findings. Goldminc and associates6 prospectively stud-
ied 35 patients undergoing TTE and 32 patients undergoing
THE and found no difference in outcomes. Chu and col-
leagues7 prospectively randomized 39 patients to TTE or
THE and also found no difference in outcomes.
All of the patients were operated on in the last decade.
Many improvements in perioperative care occurred in the
1990s. Preoperative imaging studies, such as endoscopic
ultrasonography, have improved patient selection. Epidural
catheters have dramatically improved postthoracotomy care
by allowing patients to participate more vigorously in pul-
monary toilet.8 Comparative studies that took place before
routine use of epidural catheters frequently show higher
rates of pulmonary complications among patients undergo-
ing TTE.9,10 Newer stapling devices have improved the
quality of anastomoses. Antibiotic therapy and ventilator
management also improved during the last 10 years.
Other smaller retrospective reviews have reported risk
factors for morbidity and mortality after esophagectomy
that we identified as well. Diminished functional status and
advanced age have been found to be significant risk factors
TABLE 3. Quantitative variables in 562 patients undergoing TTE and 383 patients undergoing THE
Variable TTE, mean (SD) THE, mean (SD) P value
Creatinine (mg/dL) 1.02 (0.29) 1.02 (0.3) .900
Albumin (g/dL) 3.62 (0.61) 3.72 (0.51) .010
Alkaline phosphatase (U/L) 93.3 (44.5) 90.2 (43.7) .340
Hematocrit (%) 37.8 (6.1) 39.0 (6.1) .001
Platelet count (1000s/L) 259 (99) 254 (99) .470
Prothrombin time (s) 12.2 (1.2) 12.3 (1.2) .720
BUN (mg/dL) 15.0 (7.9) 14.8 (6.8) .710
BUN, Blood urea nitrogen.
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by other groups.11 Karl and coworkers12 published a report
finding diabetes to be a risk factor for complications after
esophagectomy. Diabetes mellitus did not quite reach sta-
tistical significance in our study (P  .056). By using
retrospective data, 2 recent and large meta-analyses were
able to identify risk factors for complications after esopha-
gectomy. These meta-analyses found no difference in over-
all morbidity or mortality when comparing TTE and
THE.13,14
Older reports had noted differences between the 2 pro-
cedures. Pac and colleagues15 retrospectively reviewed 118
patients undergoing TTE and 120 patients undergoing THE
from 1983 to 1991 and determined that THEs were safer.
This study is limited by the fact that it is a retrospective
review and that TTEs were the predominant operations in
the early years of the study. The transhiatal approach was
more common later in the study.
Some groups report that the THE is a superior operation
for patients with COPD, but our study demonstrated no
difference in outcomes in this subset of patients.16 Some
authors also suggest that groups of patients undergoing THE
have fewer complications; however, we found no difference
in the rate of complications.17 It has also been suggested that
THE is better tolerated by debilitated patients.18 We found
no difference in outcomes between the TTE and THE
groups on the basis of ASA classification or functional
health status.
In conclusion, our present study demonstrates no signif-
icant differences in postoperative mortality or morbidity
between TTE and THE on the basis of a 10-year, prospec-
tive, multi-institutional nationwide study. Our work has
identified modifiable risk factors that might reduce morbid-
ity and mortality, as well as assisting in the selection of the
procedure best suited for a particular patient.
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Discussion
Dr Walter Ehrman (Loma Linda, Calif). This group has
undertaken a rather large multicenter trial to address the issue of
the relative levels of morbidity and mortality in patients undergo-
ing esophagectomy through the transhiatal and transthoracic ap-
proaches. As they have alluded to, the answer to this question has
previously been provided in small single-institution studies, but
this current study attempts to answer the same question by using a
rather large multi-institutional approach. To their credit, the au-
thors have undertaken a rather sophisticated statistical analysis to
ensure appropriate matching of preoperative variables to ensure
the validity of their data.
However, I would submit that bigger does not necessarily mean
better. There are 109 participating centers in this study, and ap-
proximately 1000 cases were performed over a period of 10 years.
That means that on average each center performed approximately
1 procedure per year. One should be skeptical about the value of
the morbidity and mortality data produced by an institution or an
individual performing a particular procedure once per year. Ap-
propriately, the authors have attempted to discriminate between
what they term high-volume and low-volume centers; however, the
point of discrimination between low- and high-volume centers is
the performance of greater than 10 procedures during the course of
the study. I would argue that the difference between performing a
procedure once and twice per year is essentially no difference at
all. The influence of the data generated by these low-volume
centers cannot be discounted because two thirds of the cases were
performed in so-called low-volume centers. A more cynical inter-
pretation of this study might be that if you perform a procedure
infrequently, then the results will most likely be the same, regard-
less of the operative approach that you choose.
There are 3 specific questions regarding standardization and
patient selection that are of some concern.
By your account, 70 patients in this study had what you called
disseminated disease at the time of surgical intervention. What
staging and screening procedures were used before inclusion in
this study?
Second, were there any attempts to standardize surgical tech-
niques, and what were the clinical or anatomic factors that guided
the decision to use a specific approach, or did it merely amount to
a dealer’s choice?
Third, you had alluded to prolonged operative time as an
independent predictor of morbidity. What is your definition of
prolonged operative time, and was the same definition applied to
all groups?
I hope to hear more on the basis of this information.
Dr Rentz. Thank you. No center had a particularly high vol-
ume of cases, with the maximum number of procedures in either
group being 27 TTEs over the 10-year period. The largest number
of esophagectomies of both types performed at one center was 44
in 10 years. This would hardly qualify as a high-volume center.
Therefore, we have chosen to remove it from the article, and I
decided not to include it in this presentation in favor of a risk-
stratification model that became available at a later period.
We did not have information on disseminated disease and
staging procedures, because this was collected from 109 centers
with a view to understanding what the patients went through and
how the decision was made.
The choice of surgical technique was left to the surgeon, and,
although we cannot say this was randomized, we do believe there
is some validity in allowing the surgeons to proceed with the
technique that they believe they are most comfortable performing.
Prolonged operative time is another issue that we evaluated,
and the operative time for the groups was similar overall, and we
looked at this as a continuous variable, meaning that we do not
have a specific cutoff for time. However, it would appear that as
operations proceed for longer periods, they will certainly have a
higher risk of morbidity.
Dr Douglas Wood (Seattle, Wash). I am sure you have been
warned about me potentially standing up and having a comment
after having discussed a similar article from the National Surgical
Quality Improvement Program (NSQIP) at the Society for Tho-
racic Surgeons’ meeting. There certainly is great value in the
analysis, and as to the results, part of them are a quantification of
what we already know. That is useful. We know that functional
status and poor nutritional status are high risk factors for virtually
any surgical intervention and certainly for larger operations, such
as esophagectomies. Having some quantification from the volume
of information that you have and a risk-stratification model is
useful information.
However, there are some potential confounding variables that
your database and your analysis of it avoid. Dr Ehrman talked
about the volume issue and that cannot be avoided. I would urge
you to look at the same issues, not by volume of greater than 10
over the course of the series but greater than 5 or 10 per institution
in a year, and to look at those volumes compared with the volumes
of the cohort overall.
The other potential confounding variable is selection bias on
the basis of expertise of surgeons. It is quite likely that general
surgeons doing esophagectomies in the VA system would prefer-
entially do THEs but potentially less frequently and with less
expertise than thoracic surgeons who might choose transhiatal or
transthoracic operations. That might have obscured a potential
benefit of THE in your series, it being masked by an unexamined
selection bias of the type of surgeons that are approaching it. Is
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there an ability with the NSQIP of looking at the volume issues
and looking at the surgeons doing the procedure to try to get better
details of comparison of morbidity and mortality between the
procedures?
Dr Rentz. Dr Wood, thank you for bringing that up. It gives me
the opportunity to speak about volume a bit more. Several, I
believe it is 5, major centers of excellence throughout the country
are joining the NSQIP, which will allow us to look at volume a bit
better and to look at these centers, which are performing quite a
few more than even 5 procedures a year. I think that will add quite
a bit in the future, but it will take a number of years to get that
online and to get good data from it.
As far as the selection bias, on the basis of your comments at
the Society of Thoracic Surgeons’ meeting, we have looked to see
whether it is possible to know who is operating on patients with
esophagectomies. It is possible through records at the VA system,
but it is not part of the NSQIP at this time.
Dr Thomas Rice (Cleveland, Ohio). It is a very nice article.
You are trying to compare 2 very dissimilar groups undergoing 2
very dissimilar operations, and I do not think you will be able to
dissect any difference with your present analysis. Have you con-
sidered doing a propensity analysis, developing matched pairs, and
seeing whether you can dissect out the difference between THE
and TTE by this approach?
Dr Rentz. Yes, I believe you are exactly right. One of our goals
was to try to understand when one operation is safer or will have
a better outcome than another one, and I think that it is a logical
next step to match them.
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